A novel purification method of murine embryonic stem cell- and human-induced pluripotent stem cell-derived cardiomyocytes by simple manual dissociation

Journal of Biomolecular Screening

Volumn 17, Issue 5, 2012, Pages 683-691

  Shinozawa, Tadahiro ^a   Furukawa, Hatsue ^a   Sato, Eimei ^b   Takami, Kenji ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

cardiomyocytes; disarray; dissociation; embryoid bodies; purification

Indexed keywords

DOXORUBICIN; TROPONIN T;

ANIMAL CELL; ARTICLE; CARDIOTOXICITY; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LABELING; CELL POPULATION; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DISSOCIATION; DRUG SCREENING; EMBRYONIC STEM CELL; HEART BEAT; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MOUSE; MYOFILAMENT; NONHUMAN; PIPETTE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REPRODUCIBILITY; TOXICITY TESTING;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SEPARATION; DOXORUBICIN; EMBRYOID BODIES; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC;

IPS; MURINAE;

EID: 84861832748     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057111434145     Document Type: Article

References (26)

1. Ebert A. D., Svendsen C. N.. Human Stem Cells and Drug Screening: Opportunities and Challenges. Nat. Rev. Drug Discov. 2010 ; 9: 367-372
2. Lian Q., Chow Y., Esteban M. A., Pei D., Tse H. F.. Future Perspective of Induced Pluripotent Stem Cells for Diagnosis, Drug Screening and Treatment of Human Diseases. Thromb. Haemost. 2010 ; 104: 39-44
3. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S.. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell. 2007 ; 131: 861-872
4. Zhang J., Wilson G. F., Soerens A. G., Koonce C. H., Yu J., Palecek S. P., Thomson J. A., Kamp T. J.. Functional Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells. Circ. Res. 2009 ; 104: e30 - e41
5. Davila J. C., Cezar G. G., Thiede M., Strom S., Miki T., Trosko J.. Use and Application of Stem Cells in Toxicology. Toxicol. Sci. 2004 ; 79: 214-223
6. Yokoo N., Baba S., Kaichi S., Niwa A., Mima T., Doi H., Yamanaka S., Nakahata T., Heike T.. The Effects of Cardioactive Drugs on Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells. Biochem. Biophys. Res. Commun. 2009 ; 387: 482-488
7. Shinozawa T., Tsuji A., Imahashi K., Nakashima K., Sawada H., Toyoshiba H., Yamamoto S., Takami K., Imai R.. Gene Expression Profiling of Functional Murine Embryonic Stem Cell-Derived Cardiomyocytes and Comparison with Adult Heart: Profiling of Murine ESC-Derived Cardiomyocytes. J. Biomol. Screen. 2009 ; 14: 239-245
8. Snir M., Kehat I., Gepstein A., Coleman R., Itskovitz-Eldor J., Livne E., Gepstein L.. Assessment of the Ultrastructural and Proliferative Properties of Human Embryonic Stem Cell-Derived Cardiomyocytes. Am. J. Physiol. Heart. Circ. Physiol. 2003 ; 285: H2355 - H2363
9. Chaudhary K. W., Barrezueta N. X., Bauchmann M. B., Milici A. J., Beckius G., Stedman D. B., Hambor J. E., Blake W. L., McNeish J. D., Bahinski A., et al. Embryonic Stem Cells in Predictive Cardiotoxicity: Laser Capture Microscopy Enables Assay Development. Toxicol. Sci. 2006 ; 90: 149-158
10. Fijnvandraat A. C., van Ginneken A. C., Schumacher C. A., Boheler K. R., Lekanne Deprez R. H., Christoffels V. M., Moorman A. F.. Cardiomyocytes Purified from Differentiated Embryonic Stem Cells Exhibit Characteristics of Early Chamber Myocardium. J. Mol. Cell Cardiol. 2003 ; 35: 1461-1472
11. Hidaka K., Lee J. K., Kim H. S., Ihm C. H., Iio A., Ogawa M., Nishikawa S., Kodama I., Morisaki T.. Chamber-Specific Differentiation of Nkx2.5-Positive Cardiac Precursor Cells from Murine Embryonic Stem Cells. FASEB J. 2003 ; 17: 740-742
12. Gassanov N., Er F., Zagidullin N., Hoppe U. C.. Endothelin Induces Differentiation of ANP-EGFP Expressing Embryonic Stem Cells towards a Pacemaker Phenotype. FASEB J. 2004 ; 18: 1710-1712
13. Huber I., Itzhaki I., Caspi O., Arbel G., Tzukerman M., Gepstein A., Habib M., Yankelson L., Kehat I., Gepstein L.. Identification and Selection of Cardiomyocytes during Human Embryonic Stem Cell Differentiation. FASEB J. 2007 ; 21: 2551-2563
14. Klug M. G., Soonpaa M. H., Koh G. Y., Field L. J.. Genetically Selected Cardiomyocytes from Differentiating Embryonic Stem Cells Form Stable Intracardiac Grafts. J. Clin. Invest. 1996 ; 98: 216-224
15. Hattori F., Chen H., Yamashita H., Tohyama S., Satoh Y. S., Yuasa S., Li W., Yamakawa H., Tanaka T., Onitsuka T., et al. Nongenetic Method for Purifying Stem Cell-Derived Cardiomyocytes. Nat. Methods. 2009 ; 7: 61-66
16. Nakagawa M., Koyanagi M., Tanabe K., Takahashi K., Ichisaka T., Aoi T., Okita K., Mochiduki Y., Takizawa N., Yamanaka S.. Generation of Induced Pluripotent Stem Cells without Myc from Mouse and Human Fibroblasts. Nat. Biotechnol. 2008 ; 26: 101-106
17. Yang L., Soonpaa M. H., Adler E. D., Roepke T. K., Kattman S. J., Kennedy M., Henckaerts E., Bonham K., Abbott G. W., Linden R. M., et al. Human Cardiovascular Progenitor Cells Develop from a KDR+ Embryonic-Stem-Cell-Derived Population. Nature. 2008 ; 453: 524-528
18. Sawyer D. B., Zuppinger C., Miller T. A., Eppenberger H. M., Suter T. M.. Modulation of Anthracycline-Induced Myofibrillar Disarray in Rat Ventricular Myocytes by Neuregulin-1beta and Anti-erbB2: Potential Mechanism for Trastuzumab-Induced Cardiotoxicity. Circulation. 2002 ; 105: 1551-1554
19. Burridge P. W., Anderson D., Priddle H., Barbadillo Munoz M. D., Chamberlain S., Allegrucci C., Young L. E., Denning C.. Improved Human Embryonic Stem Cell Embryoid Body Homogeneity and Cardiomyocyte Differentiation from a Novel V-96 Plate Aggregation System Highlights Interline Variability. Stem Cells. 2007 ; 25: 929-938
20. Mohr J. C., Zhang J., Azarin S. M., Soerens A. G., de Pablo J. J., Thomson J. A., Lyons G. E., Palecek S. P., Kamp T. J.. The Microwell Control of Embryoid Body Size in Order to Regulate Cardiac Differentiation of Human Embryonic Stem Cells. Biomaterials. 2010 ; 31: 1885-1893
21. Choi D., Lee H. J., Jee S., Jin S., Koo S. K., Paik S. S., Jung S. C., Hwang S. Y., Lee K. S., Oh B.. In Vitro Differentiation of Mouse Embryonic Stem Cells: Enrichment of Endodermal Cells in the Embryoid Body. Stem Cells. 2005 ; 23: 817-827
22. Miller R. A., Christoforou N., Pevsner J., McCallion A. S., Gearhart J. D.. Efficient Array-Based Identification of Novel Cardiac Genes through Differentiation of Mouse ESCs. PLoS One. 2008 ; 3: e2176
23. Kehat I., Gepstein A., Spira A., Itskovitz-Eldor J., Gepstein L.. High-Resolution Electrophysiological Assessment of Human Embryonic Stem Cell-Derived Cardiomyocytes: A Novel In Vitro Model for the Study of Conduction. Circ. Res. 2002 ; 91: 659-661
24. Tanaka T., Tohyama S., Murata M., Nomura F., Kaneko T., Chen H., Hattori F., Egashira T., Seki T., Ohno Y., et al. In Vitro Pharmacologic Testing Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Biochem. Biophys. Res. Commun. 2009 ; 385: 497-502
25. Billingham M. E., Mason J. W., Bristow M. R., Daniels J. R.. Anthracycline Cardiomyopathy Monitored by Morphologic Changes. Cancer Treat. Rep. 1978 ; 62: 865-872
26. Lambertenghi-Deliliers G., Zanon P. L., Pozzoli E. F., Bellini O.. Myocardial Injury Induced by a Single Dose of Adriamycin: An Electron Microscopic Study. Tumori. 1976 ; 62: 517-528